GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we handle high blood sugar. These new therapies work by mimicking the body’s own GLP-1 https://declanmeqp516929.dsiblogger.com/75074887/glp-1-a-major-advance-in-blood-sugar-management